Literature DB >> 24417873

Effect of arteriovenous hemodialysis shunt location on cardiac events in patients having coronary artery bypass graft using an internal thoracic artery.

Leonid Feldman1, Inna Tkacheva, Shai Efrati, Igor Rabin, Ilia Beberashvili, Oleg Gorelik, Zhan Averbukh, Michal Shani.   

Abstract

The possibility of developing coronary steal in patients having coronary artery bypass graft (CABG) using internal thoracic artery (ITA) and ipsilateral upper extremity arteriovenous (AV) hemodialysis shunt has been reported. The impact of this phenomenon on clinical outcomes is uncertain. The aim of this study was to investigate an association between the AV dialysis shunt location regarding the side of the ITA CABG and clinical outcomes. This retrospective cohort study included chronic hemodialysis patients having ITA CABG and upper extremity AV shunt. The patients were divided into two groups: those with ipsilateral and those with contralateral location of ITA CABG and AV shunt. The outcomes were: death from any cause, cardiac death and a first cardiac event. In a group of 112 chronic hemodialysis patients having CABG, 32 had an ipsilateral and 25 had a contralateral location of ITA CABG and an upper extremity AV shunt. Significantly more cardiac events occurred in the group with an ipsilateral compared to a contralateral location of ITA CABGs and dialysis AV shunts (hazard ratio, 2.16 [95% CI, 1.11 to 4.19], P = 0.023). There was no difference between the groups in the all cause mortality risk (hazard ratio, 1.005 [95% CI, 0.43 to 2.37], P = 0.990) or the risk of cardiac death (hazard ratio, 2.43 [95% CI, 0.64 to 9.17], P = 0.191). The ipsilateral location of a CABG with the use of ITA and upper extremity AV hemodialysis shunt may be associated with increased risk of cardiac events.
© 2014 The Authors. Therapeutic Apheresis and Dialysis © 2014 International Society for Apheresis.

Entities:  

Keywords:  Coronary artery disease; Dialysis fistula; Dialysis graft; Hemodialysis; Vascular access

Mesh:

Year:  2014        PMID: 24417873     DOI: 10.1111/1744-9987.12158

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  6 in total

1.  New Porcine Model of Arteriovenous Fistula Documents Increased Coronary Blood Flow at the Cost of Brain Perfusion.

Authors:  Anna Valerianova; Mikulas Mlcek; Tomas Grus; Jan Malik; Otomar Kittnar
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

2.  Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis "Case Report".

Authors:  Saim Sağ; Ömer Fatih Nas; Ömer Bedir; İbrahim Baran; Sümeyye Güllülü; Bahattin Hakyemez
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

3.  Effects of upper-extremity vascular access creation on cardiac events in patients undergoing coronary artery bypass grafting.

Authors:  Youngjin Han; Suk Jung Choo; Hyunwook Kwon; Jae Won Lee; Cheol Hyun Chung; Hyangkyoung Kim; Tae-Won Kwon; Yong-Pil Cho
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

4.  Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis "Case Report".

Authors:  Bülent Sarıtaş
Journal:  Anatol J Cardiol       Date:  2017-02       Impact factor: 1.596

5.  Influence of Ipsilateral Graft Inflow to Arteriovenous Fistula for Hemodialysis in Coronary Bypass Surgery.

Authors:  Bongyeon Sohn; Hyoung-Woo Chang; Jae-Hang Lee; Dongjung Kim; Junsung Kim; Cheong Lim; Kay-Hyun Park
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

6.  Long-Term Outcomes in Coronary Artery Bypass Graft Patients Using Internal Thoracic Artery with Ipsilateral Arteriovenous Shunt for Hemodialysis.

Authors:  Yung-Szu Wu; Shih-Rong Hsieh; Hao-Ji Wei; Chiann-Yi Hsu; Chung-Lin Tsai
Journal:  Acta Cardiol Sin       Date:  2019-07       Impact factor: 2.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.